Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma
| Autor: | E.J. Clark, Mark A. Taylor, Rowan W. Parks, O.J. Garden, K.K. Madhavan, C.L. Hendry, Saxon Connor |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Blood transfusion Hepatology business.industry medicine.medical_treatment Head of pancreas Gastroenterology pancreatic ductal adenocarcinoma Case Report Perioperative Malignancy medicine.disease Pancreaticoduodenectomy Surgery medicine.anatomical_structure Interquartile range Internal medicine medicine Resection margin prognosis pancreaticoduodenectomy business Survival analysis |
| Zdroj: | HPB. 9(6):472-477 |
| ISSN: | 1365-182X |
| DOI: | 10.1080/13651820701769693 |
| Popis: | Background and aims: Pancreaticoduodenectomy (PD) is a major operative intervention performed most commonly for malignancy in the head of pancreas. The aim of this study was to evaluate the utilization of blood transfusion for PD and to determine whether this had prognostic significance in a subset of patients with pancreatic ductal adenocarcinoma (PDAC). Material and methods: Data on blood transfusion requirement were retrospectively collected for patients undergoing PD from 1998 to 2005. Standard prognostic factors and survival data were also collected in patients with PDAC. Results: One-hundred-and-seventy patients underwent PD. Seventy-six patients (45%) received transfusion. The median (interquartile range) number of units of red cell concentrate (RCC) transfused perioperatively (intraoperatively and within 24h of surgery) was 1.5 (0.5–2.5). The median preoperative haemoglobin (Hb) was 126 g/dl. The median number of units of RCC transfused perioperatively in patients with Hb |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text